Published in J Pharm Belg on October 24, 1990
Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur Heart J (1997) 1.53
Aortic valve homografts in the surgical treatment of complex cardiac malformations. J Thorac Cardiovasc Surg (1984) 0.91
[Thrombolytic action of heparin and a low molecular weight fraction]. Therapie (1985) 0.88
What is the effect of acetylsalicylic acid at ultra low dose on the interaction platelets/vessel wall? Thromb Res (1990) 0.85
Thromboembolic complications several days after a single-dose administration of aspirin. Thromb Res (1998) 0.84
Effects of aspirin on embolization in an arterial model of laser-induced thrombus formation. Haemostasis (1993) 0.83
Importance of photo activation of rose bengal for platelet activation in experimental models of photochemically induced thrombosis. Thromb Res (1996) 0.83
Experimental thrombosis model induced by laser beam. Application of aspirin and an extract of Ginkgo biloba: EGb 761. Thromb Res (1996) 0.82
Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances. Thromb Res (1995) 0.82
Combination of two doses of acetyl salicylic acid: experimental study of arterial thrombosis. Thromb Res (1998) 0.81
Effect of the low molecular weight heparin/non steroidal anti-inflammatory drugs association on an experimental thrombosis induced by laser. Thromb Res (1995) 0.80
2006 GEP-ISFG collaborative exercise on mtDNA: reflections about interpretation, artefacts, and DNA mixtures. Forensic Sci Int Genet (2007) 0.79
Thrombogenic properties of ultra-low-dose of acetylsalicylic acid in a vessel model of laser-induced thrombus formation. Thromb Res (1994) 0.79
Action of neurotransmitters: acetylcholine, serotonin, and adrenaline in an experimental arterial thrombosis induced by oxygen free radicals. Thromb Res (1997) 0.79
Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis. Thromb Res (1983) 0.78
In vitro platelets/endothelial cells interactions in presence of acetylsalicylic acid at various dosages. Thromb Res (1992) 0.78
[Antithrombotic effect of piavit--a substance from the medicinal leech (Hirudo medicinalis), containing prostanoid and destabilase fractions]. Biokhimiia (1995) 0.77
Time related neutralization of two doses acetyl salicylic acid. Thromb Res (2000) 0.77
Some hemostatic and hemorheological disorders in auditory and vestibular impairments. Thromb Res (1992) 0.77
Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results. Vox Sang (1992) 0.77
Effects of aprotinin on heparin activities and heparin neutralization with protamine. Thromb Res (1992) 0.77
Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice. Thromb Res (2002) 0.76
Effects of external electrical stimulation on laser-beam-induced experimental thrombosis. Pathophysiol Haemost Thromb (2006) 0.75
Beneficial effect of ultra-low-dose aspirin in platelet activity alterations and haemorrhage observed in experimental portal hypertension. Thrombosis (2011) 0.75
[Heparin and chemically related compounds. Study in experimental thrombosis]. Ann Pharm Fr (1983) 0.75
Prevention of laser arterial thrombus formation with unfractionated heparin. Haemostasis (1994) 0.75
Effects of polyclonal antibodies against conjugated L-dopa or against conjugated acetylcholine on experimental venous thrombosis. Thromb Res (1992) 0.75
[Further data on the study of Menière's disease and menieriform syndromes]. Rev Laryngol Otol Rhinol (Bord) (1975) 0.75
Effects of acetyl salicylic acid therapy on an experimental thrombosis induced by laser beam. Thromb Res (2000) 0.75
[Hemorheological problems and alterations in erythrocyte filterability in vascular diseases]. Acta Med Port (1983) 0.75
Are molecular weight and anti-Xa activity sufficient to predict the antithrombotic power of heparin fractions. Thromb Res (1986) 0.75
[Interactions between blood and biomaterials. Applications to extracorporeal circulation]. Pathol Biol (Paris) (1982) 0.75
Comparison of the haemorrhagic effects of unfractionated heparin and a low molecular weight heparin fraction (CY 216) in rabbits. Thromb Res (1986) 0.75
[Antithrombotic agents]. Ann Cardiol Angeiol (Paris) (1993) 0.75
[Free radicals and thrombosis]. Ann Cardiol Angeiol (Paris) (1995) 0.75
[Potentiation by heparins of the action of leukocytes in experimental venous thrombosis]. Ann Pharm Fr (1988) 0.75
Is pulmonary embolism a suitable evaluation criterion of the efficacy of prophylactic treatment in surgery. Semin Thromb Hemost (1991) 0.75
[Presence of radioactivity in the gastric juice of dogs after the intracardiac injection of 3H-or 35S-labeled heparin]. C R Seances Acad Sci III (1983) 0.75
[Heart valve prosthesis and anticoagulant treatment]. Ann Cardiol Angeiol (Paris) (1993) 0.75
Haemostasis defects following cardio-pulmonary by-pass based on a study of 1350 patients. Thromb Haemost (1978) 0.75
[Preventive treatments of thrombosis of aortocoronary venous bypass]. Ann Cardiol Angeiol (Paris) (1993) 0.75
[Action of onion, Allium cepa L., on primary hemostasis in healthy volunteers before and after absorption of a high-fat meal]. Ann Pharm Fr (1985) 0.75
[Experimental models of arterial thrombosis]. Ann Cardiol Angeiol (Paris) (1995) 0.75
[Experimental models of venous thrombosis]. Ann Cardiol Angeiol (Paris) (1995) 0.75
Comparative study on the effects of a low molecular weight heparin (CY 216) and standard heparin in low dosage on experimental venous thrombosis. Haemostasis (1987) 0.75
Effect of monoclonal and polyclonal antibodies against conjugated neurotransmitter on experimental venous thrombosis. Semin Thromb Hemost (1996) 0.75
[Histologic study of venous thrombosis induced in the rat]. Ann Pharm Fr (1985) 0.75
[Low molecular weight heparins]. Ann Pharm Fr (1989) 0.75
Arterial antithrombotic effect of piyavit, the novel pharmacological preparation from the medicinal leech, and of its components, prostanoids and enzyme destabilase. Thromb Res (1995) 0.75
[Role of the indirect fibrinolytic activity of heparins and similar compounds in the prevention of thrombosis]. Ann Pharm Fr (1983) 0.75
Detection and prevention of a fibrinolysis after an extra-corporeal circulation in cardiac surgery. Thromb Haemost (1976) 0.75
[Variation of bleeding time after administration of acetyl salicylic acid at different doses in the healthy volunteer]. Ann Pharm Fr (1988) 0.75
Action of neurotransmitters: acetylcholine, adrenaline and serotonin on arterial thrombosis induced by a laser beam. Thromb Res (1996) 0.75
Aspirin fails to prevent experimental arterial thrombosis induced by oxygen free radicals. Thromb Res (1996) 0.75
[Difficulties of assessing postoperative pulmonary embolisms. Risks of meta-analysis from clinical trials]. Presse Med (1993) 0.75
[Are contrast agents prothrombotic?]. Ann Cardiol Angeiol (Paris) (1995) 0.75
Could proteolytic enzyme modulate the interaction platelets/vessel wall in presence of ASA at ultra low doses? Thromb Res (1991) 0.75
[In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine]. Ann Pharm Fr (1986) 0.75
Fibrinogen as a factor of thrombosis: experimental study. Thromb Res (1998) 0.75
Thrombogenic potential of contrast media in an experimental model of laser-induced thrombosis. Thromb Res (2000) 0.75
Platelet aggregation on whole blood after administration of ultra low dosage acetylsalicylic acid in healthy volunteers. Thromb Res (1987) 0.75
[Hemostasis]. Rev Laryngol Otol Rhinol (Bord) (1979) 0.75
[Action of prostacyclin on the extension of experimental venous thrombosis]. Ann Pharm Fr (1984) 0.75
Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterials and venous thrombosis. Thromb Res (1996) 0.75
[Biological study of Meniere's disease and Meniere's syndrome: preliminary note]. Rev Laryngol Otol Rhinol (Bord) (1975) 0.75
Effect of hirudin on the chemotactic properties of alpha-thrombin. Haemostasis (1991) 0.75
[Biochemistry of the fluids of the inner ear]. Rev Laryngol Otol Rhinol (Bord) (1976) 0.75
[Artificial blood: the future of blood transfusion? I. Hemoglobin solutions]. J Pharm Belg (1990) 0.75
Experimental venous thrombosis in rats treated with heparin and a low molecular weight heparin fraction. Haemostasis (1983) 0.75
[Variations in hemostasis in the infant under deep hypothermia]. Ann Anesthesiol Fr (1977) 0.75
The role of essential vitamins in the development of thrombosis and hemorrhage--an experimental study. Thromb Res (1992) 0.75
Effects of immuno-potent drugs and their association with an unfractionated heparin on an experimental venous thrombosis. Thromb Res (1991) 0.75
[Action of aspartate on the blood lactic acid of patients in the post-aggressive phase]. Agressologie (1973) 0.75
[Passage of commercial heparin and a low molecular weight fragment of heparin, CY 222, across the placenta of pregnant rabbits]. Pathol Biol (Paris) (1985) 0.75
[Oral administration of heparin and low molecular weight heparin fractions in rabbits]. Therapie (1984) 0.75
Aspirin and fraxiparine in the prevention of laser induced thrombosis in the presence of iodinated contrast media. Thromb Res (1998) 0.75
[Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. In vitro and in vivo study]. Therapie (1987) 0.75
The arterial antithrombotic activity of thioxylosides in a rat model of laser-induced thrombosis. Semin Thromb Hemost (1996) 0.75
Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H. activity in thrombosis? (Part II). Thromb Res (1992) 0.75
Thrombogenicity of ionic and nonionic contrast media tested in a laser induced rat thrombosis model. Thromb Res (1995) 0.75